A genomic approach to the identification and characterization of HOXA13 functional binding elements by McCabe, Colleen D. & Innis, Jeffrey W.
A genomic approach to the identification and
characterization of HOXA13 functional
binding elements
Colleen D. McCabe
1 and Jeffrey W. Innis
1,2,*
1Department of Human Genetics and
2Department of Pediatrics, University of Michigan, Ann Arbor,
MI 48109, USA
Received September 1, 2005; Revised October 19, 2005; Accepted November 8, 2005
ABSTRACT
HOX proteins are important transcriptional regu-
lators in mammalian embryonic development and
are dysregulated in human cancers. However, there
are few known direct HOX target genes and their
mechanisms of regulation are incompletely under-
stood. To isolate and characterize gene segments
through which HOX proteins regulate transcription
we used cesium chloride centrifugation-based chro-
matin purification and immunoprecipitation (ChIP).
From NIH 3T3-derived HOXA13-FLAG expressing
cells, 33% of randomly selected, ChIP clones were
reproducibly enriched. Hox-enriched fragments
(HEFs) were more AT-rich compared with cloned
fragments that failed reproducible ChIP. All HEFs
augmented transcription of a heterologous promoter
upon coexpression with HOXA13. One HEF was from
intron 2 of Enpp2, a gene highly upregulated in these
cells and has been implicated in cell motility. Using
Enpp2asacandidatedirecttarget,weidentifiedthree
additional HEFs upstream of the transcription start
site. HOXA13 upregulated transcription from an
Enpp2 promoter construct containing these sites,
and each site was necessary for full HOXA13-
induced expression. Lastly, given that HOX proteins
have been demonstrated to interact with histone dea-
cetylases and/or CBP, we explored whether histone
acetylationchangedatEnpp2uponHOXA13-induced
activation. No change in the general histone acetyla-
tion state was observed. Our results support models
in which occupation of multiple HOX binding sites is
associated with highly activated genes.
INTRODUCTION
Hox transcription factors are essential for normal growth and
patterning and regulate regional speciﬁcation along the antero-
posterior axis of the developing embryo and in the developing
limb bud (1,2). Also, alterations in Hox gene expression and
chromosomal translocations involving Hox genes have been
reported in many human cancers (3). HOX proteins bind DNA
and regulate the expression of downstream targets (4–6).
In vitro the majority of the HOX proteins bind preferentially
to the simple core sequence TAAT with the exception of the
posterior, Abdominal-B-like genes, which show preference for
the simple core sequence TTAT/C (7–9). Enhancement of
binding speciﬁcity can be accomplished through HOX protein
cofactor interaction, and HOX transcriptional activity can be
regulated through these interactions (10). HOX proteins have
also been shown to associate with chromatin modifying
enzymes, including CBP and HDACs (11–15), but the in
vivo functions of these interactions are unclear.
Despite the critical importance of HOX proteins in mam-
malian development and our knowledge of their in vitro bind-
ing site preferences, individual gene function in mammals is
complicated by functional redundancy, tissue-speciﬁc effects
and dosage effects. Additionally, a scarcity of in vivo DNA
binding sites and direct downstream targets has held up pro-
gress in elucidating mammalian HOX biochemical function.
Chromatin immunoprecipitation (ChIP) is one method used
to identify transcription factor binding sites in vivo. This
method uses formaldehyde to covalently crosslink proteins
to their native DNA binding sites followed by transcription
factor speciﬁc immunoprecipitation and DNA isolation (16–
18). For HOX proteins, this method has been used to verify
binding of HOX proteins within the promoters of selected
downstream targets (19,20) and to identify new HOX binding
sites (21), but unbiased genomic approaches to in vivo direct
HOX targets have not been reported.
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doi:10.1093/nar/gki979In this paper, we report our initial results with a genomic
approach, using ChIP, to isolate and characterize genomic
fragments that are bound by HOXA13. We took advantage
of our recent report showing that stable expression of HOX
proteins in NIH 3T3-derived embryonic ﬁbroblasts causes
reproducible expression changes of multiple genes, many of
which are biologically signiﬁcant and/or previously reported
putative HOX targets (22). We used this system to stably
express FLAG-tagged HOX proteins followed by ChIP with
anti-FLAG antibody. We used these cells to construct a library
of immunoprecipitated genomic sequences from HOXA13-
FLAG and HOXD13-FLAG expressing cells. As proof of
principle we conﬁrmed the association of HOXA13-FLAG
with a subset of these targets, assessed expression changes
of genes located close to these genomic binding locations
and explored the ability of these sequences to confer transcrip-
tional activity in transient transfection assays upon coexpres-
sion of HOXA13. With one newly identiﬁed direct target we
explored the density of HOXA13-FLAG binding to its pro-
moter region, the effects of HOXA13 coexpression in target
promoter driven reporter assays and the histone acetylation
status of ChIP-enriched gene fragments.
MATERIALS AND METHODS
Retroviral vectors and cell culture
All retroviral experiments were performed under BL2 contain-
ment and were approved by the University of Michigan Insti-
tutional Biosafety Committee. Exon 1 from Hoxa13 was
obtained by PCR ampliﬁcation and subcloned from pCMV-
HOXA13, a wild-type cDNA clone (23), and placed together
with PCR-ampliﬁed C-terminal-FLAG tagged Hoxa13 exon 2
into the BamHI site of pGem5zf+ upstream of an IRES-EGFP
cassette (22). An AgeI/XhoI fragment from this clone contain-
ing Hoxa13-FLAG-IRES-EGFP was cloned into pRet2 (24).
PCR was used to amplify and insert a FLAG-tag in-frame at
the C-terminus of Hoxd13, which was then subcloned using
AgeI/EcoRI in pRet2-IRES-EGFP (22). Cells were cultured in
high glucose DMEM (GIBCO-BRL) supplemented with 10%
fetal bovine serum, 100 U/ml penicillin, 100 mg/ml strepto-
mycin and 2 mM L-glutamine (GIBCO-BRL). Phoenix-A
amphotropic packaging cells (Gary Nolan, Stanford Univer-
sity) were transfected with retroviral plasmid vectors using
calcium phosphate Pro-Fection kit (Promega). Retrovirus-
containing medium was collected at 24, 48 and 72 h post-
transfection, ﬁltered through a 0.45 mM ﬁlter (Nalgene) and
incubated for 24 h with GP+E86 ecotropic packaging cells
(25). Infected GP+E86 cells were sorted by GFP-based FACS
to obtain a heterogeneous population of virus producing cells,
which were expanded for experiments.
Immunocytochemistry
GP+E86 expressing cell lines were plated on Growth Cover-
slips (Fisher Scientiﬁc) 24 h prior to ﬁxation. Protein expres-
sion of Hoxa13-FLAG and Hoxd13-FLAG was analyzed as
described previously (23), except cells were ﬁxed in 4% form-
aldehyde inphosphate-buffered saline (PBS) for5 min atroom
temperature, incubated with a 1:200 dilution of either rabbit
anti-HOXA13 (23) or rabbit anti-HOXD13 (MAP-peptide
with HOXD13 amino acids 176–198) primary antibody
followed by a 1:500 dilution of donkey anti-rabbit Rhodamine
conjugated secondary antibody (Santa Cruz Biotechnology).
Slides were then mounted with VECTASHIELD containing
DAPI (Vector Labs) and photographs were taken using a Zeiss
Axiophot microscope (40· objective).
Protein isolation for western blotting
Cells (estimated 70% conﬂuent) were collected by treatment
with trypsin-EDTA, pelleted and solubilized in 60 mM Tris,
pH 6.8, 2% SDS, 10 mM EDTA, 10 mM EGTA, 10% glycerol
and 1· EDTA-free protease inhibitor cocktail (Roche Applied
Sciences). Protein concentrations were determined using the
BioRad Protein Assay. Equivalent quantities of protein were
separated by electrophoresis using 12% SDS–polyacrylamide
gels and subsequently electro-transferred to nitrocellulose.
Western analysis used primary antibodies at a 1:10000
dilution of either rabbit anti-HOXA13 (23) or rabbit anti-
HOXD13. Secondary antibodies were used at a 1:15000 dilu-
tion of donkey anti-rabbit horseradish peroxide-conjugated
secondary antibody (Amersham Biosciences). All antibodies
were incubated with blots in PBST with 5% Carnation nonfat
dry milk. Protein expression was visualized using Supersignal
chemilluminescent substrate (Pierce Biotechnology).
Protein isolation for immunoprecipitation
Cells (estimated 70% conﬂuent) were collected by treatment
with trypsin-EDTA, pelleted and lysed by the addition of 1 ml
lysis buffer [1% Triton X-100, 0.1% SDS, 50 mM Tris–HCl,
pH 7.4, 150 mM NaCl, 1 mM EDTA and 1· EDTA-free
protease inhibitor cocktail (Roche Applied Sciences)] on
ice, and mechanically disrupted by aspiration and extrusion
through a 26G needle. Immunoprecipitation was preformed
using anti-FLAG M2 afﬁnity gel following the manufacturer’s
protocol (Sigma–Aldrich). Eluted proteins were separated by
12% SDS–polyacrylamide gel electrophoresis. Proteins were
electro-transferred to nitrocellulose for western analysis using
methods described above.
RNA isolation and semi-quantitative RT–PCR
RNA was isolated using Trizol (Invitrogen) and semi-
quantitative one-step RT–PCR was performed using primers
to Enpp2, Fhl1, M32486, Ppic and Ngef as described
previously (22).
ChIP
A modiﬁed version of previously reported ChIP was used (26–
28).Cells(1 · 10
8)were ﬁxedin10mM dimethyladipimidate
(DMA) in PBS for 30 min at room temperature, rinsed in PBS
and subsequently ﬁxed with 1% formaldehyde in PBS for
10 min at room temperature. Fixation was terminated by
the addition of glycine to 125 mM for 5 min at room temper-
ature. Cells were collected at 1000 r.p.m. and lysed on ice for
10 min in ChIP lysis buffer [50 mM HEPES, pH 7.5, 140 mM
NaCl, 1 mM EDTA, 0.5% NP-40, 0.25% Triton X-100, 1%
glycerol and 1· protease inhibitor cocktail (Roche Applied
Sciences)]. Nuclei were collected at 4000 r.p.m. for 10 min
andthenresuspendedinsonicationbuffer(10mMTris,pH8.0,
1 mM EDTA, 0.5 mM EGTA and 1· protease inhibitors).
Sonication was performed with a Branson 185 Cell Disrupter
on ice to an average length of 500 bp as determined by agarose
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centrifuged at 10000 r.p.m. to remove debris and adjusted to
1.42 g/ml with cesium chloride. Samples were centrifuged at
40000 r.p.m. in a Ti70.1 rotor for 48 h. 1 ml fractions were
collected from the bottom of the gradient.Fractions containing
crosslinked chromatin were combined and dialyzed versus TE
buffer (data not shown). The dialyzed samples were adjusted
to the equivalent of 1.5 · 10
7 cells/ml with immunoprecipita-
tion buffer to a ﬁnal concentration of 10 mM Tris, pH 8.0,
1 mM EDTA, 0.5 mM EGTA, 150 mM NaCl, 0.1% Triton X-
100 and 1· protease inhibitors. To obtain a PCR positive
control, 500 ml of each sample was incubated at 65 C over-
night to reverse the crosslinks, then 10 mg RNAse A and
proteinase K were added and incubated at 55 C for 3 h. Sam-
ples were extracted twice with Tris-saturated phenol followed
by extraction with chloroform and then ethanol precipitated
with 5 mg glycogen carrier. Resulting DNA was dissolved in
50 ml sterile water and quantitated using a BioRad SmartSpec
3000. The remaining chromatin samples were adjusted to con-
tain equivalent quantity of total input DNA with ChIP
immunoprecipitation buffer and to each ml 20 ml (50% slurry)
ofwashed anti-FLAGM2 agarose (Sigma–Aldrich) was added
and rotated overnight at 4 C. For each sample, agarose beads
were collected at 1000 r.p.m. and washed six times in ChIP
wash buffer (50 mM HEPES, pH 7.5, 500 mM LiCl, 1 mM
EDTA, 1% NP-40, 0.7% deoxycholate and 1· protease inhib-
itors)andthenonetimewithTE(pH8.0)each for5minonice.
Immunoprecipitated complexes were eluted with 500 ml
200 mM glycine (pH 2.5) for 5 min on ice. Each eluate
was neutralized with 1/10 vol of 1 M Tris, pH 8.0 and incub-
ated at 65 C overnight to reverse crosslinks. To each sample
10 ug each RNAse A and proteinase K were added and the
samples were incubated for 3 h at 55 C. Samples were extrac-
ted twice with Tris-saturated phenol followed by extraction
with chloroform and then ethanol precipitated with 5 mg gly-
cogen carrier. The precipitated material was resuspended in
25 ml sterile water.
Variations of this protocol used with PCR detection include
exclusion of DMA ﬁxation, exclusion of CsCl chromatin puri-
ﬁcation and/or elution by 1% SDS/0.1 M sodium carbonate.
For a typical PCR ChIP experiment 1 · 10
6 cells were ﬁxed
for 10 min with FA, lysed with ChIP lysis buffer, sonicated to
shear the chromatin to an average length of 500 bp, immuno-
precipitated directly with anti-FLAG M2 agarose (Sigma-
Aldrich) or with anti-acetyl histone H3 or anti-acetyl histone
H4 followed by collection with protein A agarose (Upstate
Biotechnology), washed in ChIP wash buffer, eluted with 1%
SDS/0.1 M sodium carbonate and DNA was collected as
described above.
ChIP fragment cloning
Cloning of DNA fragments collected by ChIP was performed
following methods described previously (29). Immunoprecip-
itated material was treated with T4 DNA polymerase and
cloned into PCR-blunt vector (Invitrogen) in 2 ml total
volume. Each ligation was transformed into XL-10 Blue
(Stratagene) chemically competent cells. The entire trans-
formation was plated onto kanamycin treated Luria broth
agar plates. Colonies with inserts were identiﬁed by PCR
using primers (50-GTGCTGCAAGGCGATTAAGTTGG-30
and 50-CCAGGCTTTACACTTTATGCTTCC-30) spanning
the cloning site in the vector. Inserts >50 bp were chosen
for sequencing at the University of Michigan DNA
Sequencing Core Lab.
ChIP PCR
PCR mixtures contained equivalent volume immunoprecipit-
ated DNA, 10 mM primer pair, 1.5 mM MgCl2, 0.2 mM each
dNTP, 1· PCR buffer (Promega) and 1.25 U Taq DNA poly-
merase (Promega) in a total volume 25 ml. Primer pairs were
designed for each of 21 fragments of interest and designed to
amplify fragments of 64–416 bp with an annealing temperat-
ureof53 C.Following 34–40 cycles of PCR ampliﬁcation,the
PCR products were resolved on a 2% agarose gel and visu-
alized using ethidium bromide staining. Primers for ChIP:
HEF1 for 50-GACAGAGAAGTTGGGAGTG-30; HEF1 rev
50-TAACGAGTCTGTGAAAGTCTA-30; HEF2 for 50-ATA-
CAACATATTTGTAAATTCTAC-30; HEF2 rev 50-
TAAATGGCATGGGTACATCTA-30; HEF3 for 50-CA-
ATGTGGCCTGCCCTTG-30; HEF3 rev 50-TGAAGGCTCA-
GAAGCTGAC-30; HEF4 for 50-ACTGGACAGTGAGGTT-
TCC-30; HEF4 rev 50-ACTGCACTGTTCTCGAAGC-30;
HEF5 for 50-GACATCTTTGTGGATTGTTCA-30; HEF5
rev 50-CACATATGTACATAAGGCATC-30; HEF6 for 50-
CAAGGAATTGGTACAGACTG-30; HEF6 rev 50-GCAT-
CACCCTTAAAGTAACATT-30; HEF7 for 50-TACCCCAT-
TATCTTTGCTGG-30; HEF7 rev 50-ACCTCAGCGTTCCA-
AGTTC-30; Enpp2 promoter A-for 50-CTGGCAGCCCCAG-
TATTTGAT-30; Enpp2 promoter A rev 50-CTCTGTCTT-
TACCATTTGTTTATTT-30; Enpp2 promoter B for 50-CAT-
CTCGAGATGGAATATATAGTAG-30; Enpp2 promoter B
rev 50-GCATAAAACCCGATAGCACAAAAG-30; Enpp2
promoter C for 50-ATTGTCTACATTACCAGGCTCAG-30;
Enpp2 promoter C rev 50-TGTCTCCACCCCCAACAGGG-
30; Enpp2 promoter D for 50-GATGAACGGTTACTCACA-
GATC-30; Enpp2 promoter D rev 50-AGGCAAGCTTCAA-
TACAAATGCC-30; Enpp2 transcription start for 50-TTGCC-
TTAAGCCTCTTCTGC-30; Enpp2 transcription start rev 50-
CCTGGTATGCCCGAAACAG-30.
Vectors, transient transfections and
transcriptional activity assay
To isolate the chicken b-actin minimal promoter pTriEx1.1
(Novagen) was digested with SacII/NsiI, which was cloned
into pGL3-basic modiﬁed to contain a SacII and NsiI site
between HindIII and BglII (pGL3-b-actin). HEFs cloned
into PCR-blunt were digested with EcoRI and subcloned
into EcoRI digested pBluescript II SK+ (Stratagene). pBlue-
script cloned HEFs were digested with SacI/XbaI or SacI/KpnI
and cloned upstream into pGL3-b-actin digested with either
SacI/XbaI or SacI/KpnI to obtain both orientations. The pro-
moter region of Enpp2 was ampliﬁed using PCR: P1 ¼ 50-
CTTGGAAAACCTCTGCAGGGTG-30;P 2 ¼ 50-ATTGTC-
TACATTACCAGGCTCAG-30 and cloned in the forward
orientation into pGL3-basic (Promega). Site-directed muta-
genesis was performed (Stratagene) using oligos: mutA 50-
GAAGTAGCTGACAATGTATCCCCATAGATACAGGG-
TCATTC-30;m u t B5 0-GAAAAACCTTACATGGGGTCC-
CCATCTTTTAGAAGCCTTGC-30;m u t C5 0-TATTTGAGA-
TAATGAGAGTCCCCTGTGTTTTACAGTTGATTC-30.C o s 7
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pbactin-bgal (a gift from Didi Robins), and either pCMV5
or pCMV-HOXA13 (23). A total of 125000 COS7 cells
were plated per well in 12-well dishes, in triplicate per con-
dition,24 hpriortotransfection. Fugene-6transfection reagent
(Roche) was used according to the manufacturer’s directions.
An aliquot of 800 ng total DNA was used per transfection and
2.4 ml total transfection reagent per well. Twenty-four hours
post-transfection cell lysates were prepared by rinsing cells
two times in PBS followed by incubation for 15 min at room
temperature in 200 ml Passive Lysis Buffer (Promega). Each
well was scraped and collected into microfuge tubes, vortexed
and the debris was pelleted by centrifugation at 4 C. Super-
natant solutions were subsequently used in b-galactosidase
and luciferase activity assay systems following the manufac-
turer’s protocols (Clontech and Promega, respectively) using a
Monolight 3010 luminometer (PharMingen).
Quantitative RT–PCR
First strand cDNA was synthesized from 1 mg total RNA,
isolated as described above, using Superscript First Strand
cDNA synthesis kit following the manufacturer’s protocol
(Invitrogen). cDNA equivalent to 10 ng RNA was used in
Taqman Gene Expression Assays (Applied Biosystems)
following the manufacturer’s protocol. Each sample was
performed in triplicate. For each reaction 15 ml cDNA in
sterile water, 4 ml5 · SurePRIME and GO reaction mixture
(Qbiogene Inc.), and 1 ml Taqman Gene expression assay for
Ube2v2 (Mm00786385_s1), Mcm4 (Mm00725863_s1) or
Hprt (Mm00446968_M1) was used. PCR was performed
using an ABI Prism 7700 sequence detection system and soft-
ware (Applied Biosystems). The results were analyzed using
the comparative CT method (Applied Biosystems).
RESULTS
Creation and characterization of cell lines
In a recent report, we described the use of a retroviral system
for creating stable cell lines expressing members of the Hox
family of genes and demonstrated reproducible gene expres-
sion changes (22). We used this approach to create stable cell
lines expressing C-terminal FLAG-tagged HOXA13/EGFP
and C-terminal FLAG-tagged HOXD13/EGFP with retroviral
vectors modiﬁed with bicistronic C-terminal FLAG Hox-
IRES-EGFP expression cassettes as described in Materials
and Methods. The control HOX ( ) cell line used was pre-
viously described and exhibited no HOXA13 or HOXD13
RNA or protein (22).
To conﬁrm expression and nuclear localization of
HOXA13-FLAG or HOXD13-FLAG proteins, we used west-
ern analysis and immunocytochemistry. The HOXA13-FLAG
and HOXD13-FLAG cells expressed nuclear localized FLAG-
tagged HOXA13 or HOXD13 (Figure 1A and B). To conﬁrm
that FLAG-tagged HOX proteins also reproducibly alter gene
expression we performed semi-quantitative RT–PCR
(Figure 1C). Gene expression changes for Ngef1, M32486,
Enpp2 and Fhl1 were consistent with those we reported for
the non-tagged HOX proteins (22). Anti-FLAG M2 agarose
immunoprecipitation experiments showed that the
FLAG-tagged HOX proteins could be immunoprecipitated
from total cell lysates (Figure 1A). Thus, these cells produce
FLAG-tagged, nuclear localized HOX proteins and exhibit
expected changes in gene expression.
Generation of Hox-enriched fragments (HEFs)
To isolate DNA segments associated with HOXA13 and
HOXD13 in vivo we used ChIP after crosslinking of protein
to DNA. Formaldehyde (FA) is a protein–DNA crosslinker
that covalently links amino acids with a primary amine group
to DNA through cytosine (30). HOX DNA binding sites are
adenine- and thymidine-rich, and we hypothesized that FA
alone may not be sufﬁcient to crosslink HOX proteins to
DNA. Second, if HOX proteins in some cases are not directly
bound to DNA but are part of multiprotein complexes (31,32),
FAcrosslinkingalonemaynotallowforreproduciblerecovery
of fragments. Homeodomain proteins have been shown in
some contexts, including our cells (22), to retain function in
the absence of in vitro monomeric DNA binding capability
(9,33,34). For these reasons, DMA was included as a pre-FA-
crosslink step. DMA promotes formation of covalent protein–
protein crosslinks (35) thereby crosslinking HOX proteins to
putative DNA-binding protein cofactors that could then be
subsequently crosslinked to DNA through FA. Cesium chlor-
ide (CsCl)-based chromatin isolation was used to minimize
recovery ofrepeatedsequences and free DNA and toenrich for
protein-crosslinked DNA (26).
The HOX ( ), HOXA13-FLAG and HOXD13-FLAG cells
were subjected to crosslinking, lysis, sonication, chromatin
isolation by CsCl centrifugation and immunoprecipitation as
described in Materials and Methods. For a typical experiment
100 million cells produced  340 mg DNA in the crosslinked
chromatin prior to immunoprecipitation. After immunoprecip-
itation direct assessment of the amount of DNA obtained was
not performed. Eluted DNA fragments were cloned without
PCR ampliﬁcation and colonies from the resulting transforma-
tionswere screened forinserts usingvector-speciﬁc primers. A
total of100colonies(50of934HOXA13-FLAG and50of826
HOXD13-FLAG derived clones) were randomly screened
and, of those screened, 87 had inserts ranging from 43 to
1152 bp (data not shown). A total of 25 of 724 colonies
were screened from the control HOX ( ) cells and the size
variation was consistent with those from the HOX group
13 expressing cells (data not shown). Clones that were determ-
ined to be 100% repeated sequence by RepeatMasker (http://
www.repeatmasker.org) were not included for further analysis
(19 clones). While carryover of some repeats was expected as
reported by other studies, it is difﬁcult to evaluate whether
these fragments are speciﬁcally associated with HOX proteins
(36). An additional 13 sequences were of unknown origin,
meaning that their identity could not be found in the NCBI
m33 Feb 05 database. Thus a total of 32 sequences were
excluded from further analysis.
The remaining 55 ChIP fragments were prioritized based
on their genomic locations. Twenty-one fragments fulﬁlled
prioritization requirements detailed below. Of these twenty-
one, seven were found to be within 500 kb of a gene whose
expression was shown to be signiﬁcantly altered in HOXA13
expressing cells (22); nine individual clones contained at
least 50 bp of sequence that was conserved a minimum of
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the closest gene to nine fragments was a gene known to be
important in limb development or a transcription factor; and
eight were located within 5 kb of the putative transcription
start site of any gene. Ten fragments fell into more than one of
these categories and were placed at the top of the priority list
(Table 1). Of the remaining 34 clones, 11 were located in
intragenic regions outside of the ﬁrst 5 kb of transcribed
sequence. A total of 23 were in intergenic regions over 5 kb
away from the transcription start site of the closest gene,
within regions not conserved in human syntenic sequence,
and over 500 kb away from any gene signiﬁcantly altered
in expression in HOXA13 expressing cells.
Seven of twenty-one ChIP-cloned fragments
are reproducibly enriched
The21clonedfragmentsfromtheprioritizationwere testedfor
reproducibility of enrichment using ChIP and 7 (33%) frag-
ments, hereafter referred to as HEFs, were consistently
enriched in the HOXA13-FLAG cells compared with the
HOX ( ) cells (Figure 2). Enrichment of these HEFs from
the HOXD13-FLAG cell line was variable. The reproducib-
ility of HEF enrichment as well as the consistent
non-enrichment of other fragments cloned from these cells
support our conclusion that HOXA13-FLAG can be
recovered in association with speciﬁc DNA regions within
Figure 1. Characterization of HOXA13-FLAG/EGFP or HOXD13-FLAG/EGFP expressing cells. (A) Western blot using HOX-specific antibodies demonstrating
HOXA13expressionand anti-FLAG immunoprecipitationfromHOXA13-FLAGcell lineand absentHOXA13expression in the HOX ( ) cell line (1);HOXD13-
FLAG expression and anti-FLAG immunoprecipitation from HOXD13-FLAG cell line but absent HOXD13 expression in the HOX ( ) cell line (2). (B)
ImmunocytochemistryusingHoxspecificantibodiesandDAPIstainingdemonstrateexpressionandnuclearlocalizationofHOXA13orHOXD13intheirrespective
cell lines.(C) InputRNAusingserial dilutionsrangingfrom156pg to 10ngwasusedin semi-quantitative RT–PCRto lookforexpressionchangesoffourreported
targets. Fhl1 (+6-fold), Enpp2 (+18.8-fold) and M32486 (+2.3) are upregulated in the HOXA13-FLAG (A) and HOXD13-FLAG (D) cell lines and Ngef ( 2.4) is
downregulatedcomparedtoHOX( ).Water(W)wasusedasaPCRcontrol.PpicwasaloadingcontrolandwasshowntobeunchangedintheHOXA13-FLAGand
HOXD13-FLAG cell lines.
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NEF2) as negative controls in later experiments.
Sequence comparisons between the 7 HEFs and the 14
NEFs showed few differences. A signiﬁcant increase in the
%A–T in the HEFs (average 58.9%) versus NEFs (average
50.5%) (student’s t-test P ¼ 0.029) was observed. While ﬁve
of the top six fragments with the highest %A–T were repro-
ducibly enriched, HEF4 and HEF7 lie below the average at 48
and 49.5%, respectively (Table 1). This shows that while the
%A–T may be a general indicator of HOXA13 association it
alone cannot determine whether a fragment will be reprodu-
cibly associated with HOXA13 in chromatin. Moreover, 4
HEFs also contained 1 or 2 matches to 7 bp HOX group 13
binding sites (9,20); however of the other 14 fragments, 3 also
had 1 or 2 of these sites, a number not statistically different
(P ¼ 0.111).
HEFs are enriched independent of DMA crosslinking
and CsCl chromatin purification
To test the necessity for DMA to obtain enrichment of HEFs,
we performed ChIP on HOXA13-FLAG cells and HOX ( )
cells each with or without DMA ﬁxation using HEFs1–7 and
NEF1 (Figure 3A and data not shown). Enrichment in
HOXA13-FLAG cells relative to HOX ( ) cells for each
HEF was still apparent without DMA treatment; however,
for HEF1 upon addition of DMA the enrichment was visibly
better ( 1.9-fold). This demonstrates that DMA addition may
help recover a selective population of fragments, but may not
be necessary.
Chromatin puriﬁcation via CsCl centrifugation was used to
minimize the number of repeated sequence and free DNA
fragments cloned into the library and to enrich for crosslinked
chromatin as the source for ChIP input. The availability of
HEFs allowed us to test whether the CsCl puriﬁcation was
necessary to obtain enrichment of selected fragments using
PCR. ChIP was performed on HOXA13-FLAG cells and HOX
( ) cells side-by-side with and without chromatin puriﬁcation.
HEF enrichment was still robust and, for HEF2, more apparent
without CsCl chromatin puriﬁcation (Figure 3B and data not
shown). Importantly, NEF1 was similarly not enriched under
each condition (Figure 3B). The consistent HEF enrichment
using several manipulations of ChIP supports our conclusion
that the fragments recovered reproducibly from these cells are
associated with HOXA13-FLAG in cellular chromatin.
Ube2v2 is upregulated in HOXA13 expressing cells
To correlate gene regulation with HEF location, we examined
whether endogenous genes near HEF1 and HEF2 show altered
expression in the HOXA13-FLAG cells versus the HOX ( )
cells. HEF2 lies within the second intron of Enpp2 whose
expression is highly upregulated in these cells as demonstrated
by semi-quantitative RT–PCR (Figure 1C). The next closest
genes to HEF2 are 2600005O03Rik (210 kb away) and Nov
(150 kb away). While the Riken gene was not represented on
Affymetrix array MG_U74Av2, the expression of Nov was not
altered in previous microarray data (22). Thus, Enpp2 is the
only gene close to HEF2 for which HOXA13 expression is
known to change steady-state RNA levels.
For HEF1, we used real-time PCR. HEF1 is located 30 kb
upstream of Ube2v2 and 500 bp downstream of Mcm4 on
mouse chromosome 16. The steady-state RNA abundance
of Ube2v2 was increased (2.5-fold) in the HOXA13-FLAG
cells, while the expression of Mcm4 was unchanged, demon-
strating a gene-speciﬁc effect of HOXA13-FLAG expression
in these cells (Figure 4). The proximity of HEF1 to Ube2v2
and the upregulation of Ube2v2 in the HOXA13-FLAG cells
suggest that HOXA13 binding to HEF1 may modulate Ube2v2
expression in vivo.
HEFs are capable of modifying reporter activity in vitro
To test the transcriptional activity function, each HEF (1 copy)
was cloned into a luciferase reporter plasmid with a minimal
promoter and tested for transcriptional regulation by
HOXA13. Recently, HOXA13 was reported to enhance
(1.8- to 2.0-fold) reporter expression via a fragment in the
promoter region of BMP7 (20). We cloned this fragment
into our reporter vector and used it as a positive control for
HOXA13 function (Figure 5A).
Coexpression of HOXA13 with the HEF-reporter plasmids
revealed an orientation-independent increase in luciferase
activity when compared with control transfections lack-
ing HOXA13 (Figure 5B). The HOXA13-induced HEF tran-
scriptional enhancement ranged from 1.3- to 2.6-fold and
Figure 2. Representative PCR enrichment of HEFs. ChIP was performed in
HOXA13-FLAG, HOX ( ) and HOXD13-FLAG cell lines using anti-FLAG
agarose. PCR detection was performed using primers specific to each HEF,
NEF1 and NEF2. NEF1 resulted in no detectable product for each cellular
sample and NEF2 resulted in product with no detectable difference between
the HOXA13-FLAG or HOXD13-FLAG cell lines and the HOX ( ) cells.
Water wasused as a negative PCR control and inputChIP DNA from the HOX
( ) cells was used as the positive PCR control.
Nucleic Acids Research, 2005, Vol. 33, No. 21 6787transcription of the BMP7 positive control was increased by
2.5 in the forward orientation and 3.2-fold in the reverse ori-
entation over empty vector control. As a negative control,
NEF1 was cloned into the reporter vector and, when coex-
pressed, HOXA13 was unable to change reporter activitydem-
onstrating a fragment speciﬁc effect (Figure 5A). The recovery
of these fragments using ChIP and their ability to drive
reporter expression in the presence of HOXA13 indicates
that HOXA13 is able to mediate enhancement of gene expres-
sion in vivo via these fragments.
HOXA13 is bound to the Enpp2 promoter in vivo
In transient experiments, HOXA13 was able to enhance
reporter expression driven by HEF1 2-fold, consistent with
the endogenous gene expression change upon HOXA13
expression in the stable cell lines. However, HEF2 maps to
intron 2 of Enpp2 whose endogenous expression in HOXA13-
FLAG cells was found to be at least 18-fold upregulated as
determined by gel signal analysis(BioRadQuantity One 4.2.1)
(Figure 1C) (22). HOXA13 was able to enhance reporter
expression driven by HEF2 by 1.5- to 1.7-fold, which does
not completely account for the expression level difference
seen between the cell lines. In Drosophila homeotic proteins
eve and ftz were shown to bind at uniformly high levels
through the genomic locus of their activated target genes
(37). It is possible that the same phenomenon is seen in the
mammalian genome and together multiple binding site occu-
pancy may result in a larger expression change. We hypothes-
izedthat multiple, additional binding sites for HOXA13 within
the Enpp2 gene, and possibly other genes whose expression
was determined to be highly upregulated in these cells, could
explain the higher level of expression.
To identify potential HOXA13 binding sites within Enpp2,
we searched 3.6 kb upstream of the start methionine (ATG) of
the mouse Enpp2 gene for putative binding sites similar in
sequence to those previously reported (20). We incorporated
nucleotide variations to reﬂect core binding site differences
found in vitro (9). This region of the Enpp2 promoter is highly
conserved to the homologous human sequence, which has been
shown to contain transcription start sites at  64 bp and  61 bp
(38). Three putative HOXA13 binding sites were identiﬁed at
 563 bp,  1491 bp and  2480 bp (Figure 6A). PipMaker
(http://pipmaker.bx.psu.edu/pipmaker/) was used to determine
the conservation of this region to the human Enpp2 upstream
region. All three potential HOXA13 binding sites fall within
human/mouseconservedregionswithidentity>50%over50bp;
however, only the 7 bp putative HOX binding site at  1491 bp
is 100% conserved over the entire 7 bp (Figure 6A). Within
these conserved regions there are several additional candidate
HOXA13 binding sites present only in the human sequence;
thus the location of candidate sites are not always conserved
between species.
PCR primers were designed around the three candidate
mouse sites (A–C) as well as one additional upstream segment
devoid of any putative HOX binding motifs (D) as a control.
PCR with these primers was used to look for enrichment in
HOXA13-FLAG cells versus HOX ( ) cells in an anti-FLAG
ChIP experiment (Figure 6B). PCR surrounding the potential
binding sites A and B and to a lesser extent C consistently
demonstrated ChIP enrichment in the HOXA13-FLAG cells.
PCR surrounding site D consistently showed no enrichment.
To our knowledge this is the ﬁrst study to demonstrate binding
by a mammalian HOX protein across a genetic region at mul-
tiple sites encompassing the promoter as well as the tran-
scribed region of an endogenous target gene.
Enpp2 promoter activity is augmented by HOXA13
expression in vitro in transient transfections
Since ChIP enrichment could be correlated to increased Enpp2
expression we sought to test the ability of HOXA13 to regulate















(NCBI m33 Feb 05)
Size % AT Number of
replicates
enriched
BC024683 Intron 2 (BC024683) 3 88826566 98 44.3 1 of 5
C79747 300 kb Intron 2 (PPP2ce) 3 69879357 174 50.6 0 of 5
HEF1 Ube2v2 28 kb Yes Mcm4 16 15397757 589 58 5 of 5
HEF2 Enpp2 Intragenic Enpp2 Intron 2 (Enpp2) 15 55091172 140 73.6 5 of 5
P4ha2 218 kb Acsl6 11 53985541 68 47 0 of 5
HEF3 Ttrap 175 kb Intron 1 (6330500D04) 13 24035157 211 57.8 5 of 5
Yes Ppp1r12b 1 134718064 269 50.2 1 of 5
HEF4 Yes Intron 1 (LOC215415) 1 37422455 373 48 5 of 5
NEF1 Yes Intron 1 (LOC384064) 4 132506680 77 51.7 1 of 5
HEF5 Rbms1 Intron 1 (Rbms1) 2 60887764 250 68.8 4 of 5
Trpm7 360 kb 2 126185532 243 51.9 2 of 5
Upstream (LOC233053) 7 23326578 552 58.4 1 of 5
Ngfb 425 kb 3 102877953 307 52.8 0 of 5
Yes 10 20442119 412 52.4 2 of 5
NEF2 Yes 10 30931007 315 56.2 2 of 5
Yes 17 26568731 153 49 0 of 5
Yes 6 89186862 135 38.5 0 of 5
Yes 4 102043918 570 52.5 1 of 5
HEF6 Unc84b 15 80062394 160 56.3 4 of 5
Fhl2 1 43504079 283 52.3 1 of 5
HEF7 Foxn2 17 86974455 918 49.5 4 of 5
aWilliams et al. (22).
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tion assay. We cloned a segment of the promoter,  35 bp to
 2541 bp relative to the start methionine, upstream of luci-
ferase in the pGL3-Basic vector (Promega) (Figure 7A). We
cotransfected the reporter construct, a b-Galactosidase expres-
sion vector to normalize for transfection efﬁciency, and
increasing concentrations of HOXA13 expression vector
and then tested for reporter activity 24 h after transfection.
Luciferase activity increased in a HOXA13 dose-dependent
manner (Figure 7B).
To test the necessity of each putative HOXA13 binding site
within the Enpp2 promoter region on reporter expression
Figure 3. HEFenrichmentwithoutprotein–proteincrosslinkingandchromatin
purification. (A) ChIP was performed in HOXA13-FLAG and HOX ( ) cells
using anti-FLAG agarose. Elimination of crosslinking with DMA preceding
formaldehyde crosslinking is represented in indicated lanes [DMA( )]. HEF1
and HEF2 are enriched upon addition of DMA as well as without DMA in the
HOXA13-FLAG versus HOX ( ) cells. HEF1 demonstrated a visibly higher
signal with DMA versus DMA ( ) in the HOXA13-FLAG cells (1.9-fold by
BioRad Quantity One analysis) while HEF2 recovery was equal between the
samples. (B) ChIP was performed in HOXA13-FLAG and HOX ( ) cell lines
usinganti-FLAGagarose.CsClpurificationofchromatinwaseliminatedinthe
indicated samples ( ). HEF1 and HEF2 are both enriched in the HOXA13-
FLAG cells versus the HOX ( ) cells both with and without chromatin pur-
ification. There was consistently no product in the HOX ( ) sample for HEF1;
however, there is a product present in the CsCl purified HEF2 sample.
Figure 4. Ube2v2isupregulated2.5-foldinHOXA13-FLAGcells.InputRNA
isolated from HOXA13-FLAG and HOX ( ) cell lines were used in real time
PCR assays for Ube2v2 and Mcm4. Hprt was used as a loading control to
normalize the values between cell lines. Ube2v2 expression was 2.5-fold up-
regulatedin the HOXA13-FLAG cell versusthe HOX ( ) cells.Mcm4 expres-
sion was not changed between cell lines.
Figure 5. HOXA13 enhances transcription from HEFs. (A) The enhancer
region of Bmp7 (20) was cloned upstream of the chicken b-actin minimal
promoter driving luciferase and cotransfected in COS7 cells with CMV-
HOXA13 or pCMV as a positive control for HOXA13 function. Addition of
CMV-HOXA13 resulted in a 2.5- to 3.1-fold increase in activity over empty
vector. NEF1 was also cloned upstream of the chicken b-actin minimal pro-
moter driving luciferase and used in the same assay resulted in no detectable
difference in normalized reporter activity upon addition of CMV-HOXA13
over empty vector. A b-galactosidase expression vector was cotransfected as a
transfection control and all samples were normalized to its activity. (B) HEFs
wereclonedinbothaforwardandreverseorientationupstreamofthechickenb-
actinminimalpromoterdrivingluciferaseandcotransfectedinCOS7cellswith
CMV-HOXA13 or pCMV. Luciferase reporter activity upon addition of
HOXA13 resulted in a significant (*P < 0.01; **P < 0.05) increase in relative
luciferase activity when compared with identical transfections with control
pCMV vector. A b-galactosidase expression vector was used as a transfection
control and all samples were normalized to lacZ activity.
Nucleic Acids Research, 2005, Vol. 33, No. 21 6789we used site-directed mutagenesis to alter the core AT-rich
binding sites of each putative site (Figure 7C). When sites B
and C were individually mutated partial activation of the
reporter was observed. However, when site A was mutated
no signiﬁcant activation was achieved. Thus, site A appears to
be the most indispensable for activation. However, each site
was necessary for full activation by HOXA13. Therefore,
HOX-activation of this target gene may be realized through
a net-additive effect of occupancy of multiple sites.
Enpp2promoterhistoneacetylationstateisnotalteredin
HOXA13-FLAG cells
HOX proteins are likely to achieve their regulator function
through interactions with coactivators and corepressors. One
such class of coregulators is histone-acetylation state modify-
ing enzymes (39). Members of the HOX family of proteins
have been shown to interact with histone deacetylases
(HDACs) (12,15) as well as the histone acetyl transferase
(HAT), CBP (11–13). The effect of HOX protein/HDAC or
HOX protein/CBP interactions on the acetylation state of his-
tones at in vivo HOX binding sites is unknown.
To test whether HOXA13-FLAG occupancy at the Enpp2
promoter has an effect on the overall acetylation status of local
histones we performed ChIP using anti-acetyl (K9 and K14)
histone H3 and anti-acetyl (K5, K8, K12 and K16) histone H4
(Upstate Biotechnology) which includes residues acetylated
by CBP (histone H3 K14; histone H4 K5) (40,41). PCR for
fragments A, B, C, D, HEF2 and primers surrounding the
Enpp2 transcription start site were used. There was no enrich-
ment for acetyl-histone H3 or H4 within the loci bound by
HOXA13 or at the transcription start site in the HOXA13-
FLAG cellline versus the HOX ( )cellline (Figure 8and data
notshown).Aregion ofGAPDHwas usedasa positivecontrol
and was equally recovered between the two cell types. A
region of the mouse Ey-globin locus (Ey) was used as a neg-
ative control and was not recovered from both cell types as
expected. Our results indicate that HOXA13 does not affect
the general acetylation status of histones when bound at the
Enpp2 genetic locus as detectable by this method; however,
this experiment does not eliminate the possibility that
HOXA13 may be affecting the acetylation of a single histone
residue not detectable using these general acetyl histone
antibodies or otherwise involving other chemical histone
modiﬁcations.
DISCUSSION
Using a ChIP-based cloning approach, we identiﬁed novel
HOXA13 genomic binding regions. We found that 33% of
the randomly selected ChIP clones were reproduciblyenriched
in independent ChIP assays. To our knowledge, these HEFs
represent the ﬁrst reported mammalian HOX binding sites
outside of the immediate upstream regions of candidate
genes. The HEFs ranged in location from 3 to 80 kb from
their closest gene lending evidence to the hypothesis that HOX
proteins can bind and may function at considerable distances
from the promoters of genes.
Emphasis on deﬁning a HOX binding sequence has led to
the use of in vitro methods to deﬁne the DNA binding
sequence for HOX proteins (42). However, the existence of
a putative site within the genome does not necessarily indicate
that a HOX protein would be bound in vivo or even functional
when bound (1,43–45). Thus, using sequence information
alone overestimates the library of putative sites within regions
of target genes and the prospect of long-range (megabase)
interactions, as demonstrated for some enhancers (46), further
complicates the identiﬁcation of relevant binding sites in
silico. Additionally, variable ﬂanking DNA sequences (47)
may confer modest binding afﬁnity differences for individual
sites. Occupancy of sites will also vary between tissues and
may be dependent on HOX protein expression level, chro-
matin conformation and presumably the presence of cofactors.
Therefore, assessing whether an in silico site is occupied and
functional in vivo requires experimental exploration as we
have shown.
Chromatin immunopurification protocol modifications
To obtain the purest population of authentic HOXA13 binding
fragments, we included DMA crosslinking and chromatin
Figure 6. Candidate HOXA13 binding sites in the Enpp2 upstream region are
enriched in HOXA13-FLAG expressing cells. (A) Candidate in vivo binding
sites for HOXA13 were identified upstream of the mouse Enpp2 translational
start methionine (ATG) using in vitro core sequence variations (9,20) and are
labeled with their position relative to the ATG. The plot resulting from an
analysis using Advanced Pipmaker (http://pipmaker.bx.psu.edu/pipmaker/)
shows sequence conservation to the region upstream of the human Enpp2 start
codon. The candidate HOXA13 binding sites’ locations in the mouse sequence
are shown as vertical colored lines. The site conserved between mouse and




(A–C) as well as one additional sequence within the mouse Enpp2 promoter
region without a putative HOXA13 binding motif (D). (B) Chromatin was
prepared from HOXA13-FLAG expressing and HOX ( ) cells and subjected
to anti-FLAG ChIP. The DNA recovered from the ChIP experiments was used
in PCR for the sites upstream of the Enpp2 mouse promoter (A–D). Repro-
ducible enrichment (n ¼ 4) of sites ‘A’ and ‘B’ and to a lesser extent ‘C’ was
observed in HOXA13-FLAG expressing cells. Site ‘D’ was not detectably
enriched between cell lines.
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cloned. These steps were included in previous reports and
signiﬁcantly increased enrichment of fragments (26,35).
Using this technique we showed that 33% of clones tested
were reproducibly enriched in up to ﬁve independent ChIP
experiments,consistentwith whathasbeen reportedwithChIP
followed by cloning (29,48–50). In our hands, DMA cross-
linking and CsCl-based chromatin puriﬁcation are not
necessary to obtain enrichment. However, the proportion of
ChIP-derived clones that could be obtained from exclusion of
these steps was not tested and could be <33%.
HEFs and gene expression
Three (HEF1, HEF2 and HEF3) of the seven HEFs were loc-
ated within 500 kb of a gene that was changed in expression in
HOXA13 stable cells. HEF1 was located 28 kb upstream of
Ube2v2, HEF3 was located 175 kb upstream of Ttrap, and
HEF2 was located within the Enpp2 gene. However, we only
sequenced  5% of the total clones and it is reasonable to
expect that within the library there are many additional clones,
mapping within or immediately upstream of transcriptionally
altered genes. Additionally, it is possible that we did not detect
expression changes in genes near each of the other HEFs for
several reasons. (i) Chromatin structure may inhibit the ability
of HOXA13 to exert function on nearby genes. (ii) There may
be absence of necessary cofactors in certain genomic regions
as suggested by the widespread binding model (4). (iii) The
level of gene expression change may have been below the
level of detection or signiﬁcance for the microarray assays.
HEF2 was located in intron 2 of Enpp2. The vast increase in
the expression of Enpp2 in these cells is consistent with the
data in Drosophila of multiple binding sites within a single
genetic locus that might account for the large expression
change (37). We were able to use ChIP to demonstrate repro-
ducible enrichment of fragments located in the immediate
upstream region of the Enpp2 promoter and at least four
HOXA13 associated fragments are present within this region
Figure7.HOXA13augmentstranscriptionalactivityfromthemouseEnpp2promoter.(A)PCRwasusedtoamplifytheregion 35to 2541upstreamofthemouse
Enpp2 start methionine and cloned into the pGL3-basic vector in a forward orientation. (B) Cotransfection of the Enpp2 promoter-driven luciferase reporter vector
withincreasingconcentrationsofHOXA13relativetoemptyvectorresultsinadosedependentincreaseinreporteractivity.Ab-galactosidaseexpressionvectorwas
cotransfected as a transfection control and all samples were normalized to its activity. (C) Site-directed mutagenesis was used to change the AT-rich core of each
putativeHOXbindingsitewithintheEnpp2promoterinthecontextofthepGL3vector.ThesevectorswerecotransfectedwithincreasingconcentrationsofHOXA13
plasmid. A marked reduction of relative luciferase activity at each HOXA13 concentration tested was seen for each individually mutated site A, B or C when
comparedwiththewild-typepromoter.SignificantincreasesinluciferaseactivitywereobserveduponadditionofHOXA13(*P < 0.01;**P < 0.05)withmutantB
and mutant C but not mutant A.
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analysis of the entire Enpp2 genetic locus, perhaps with ChIP
followed by microarray hybridization (51), would reveal sev-
eral additional fragments. The genomic extent of HOXA13
occupancy over the Enpp2 locus would be interesting to deter-
mine and might shed light on the mechanism that HOX
proteins use to regulate their downstream targets.
Dose-dependent HOXA13 response
Similar to other HOX family members, HOXA13 and
HOXD13 have been shown to demonstrate a gene dosage-
dependent effect in their regions of expression, including
the developing limb bud, digestive tract and urogenital tract
(52–56). The promoter region of Enpp2 demonstrates a dose-
dependent increase in reporter gene activity upon HOXA13
addition (Figure 7B). Our data support a model that quantit-
ative regulation of HOX direct downstream targets is one
method in which dose dependency can be realized (57).
This could be accomplished through the use of multiple bind-
ing sites. While we have shown only one gene with multiple
sites, our data are also consistent with that from Drosophila
showing the accumulation of multiple, functional binding sites
within homeotic target genes (37,58).
HOXA13 does not affect local histone acetylation status
at the Enpp2 promoter
Two models to explain HOX protein binding site speciﬁcity
are the activity regulation model (4,59,60) and the binding site
selection model(61).For eithermodelHOX proteinsare likely
to achieve their transcriptional regulation through association
withcoactivators andcorepressors. Wefoundno differencesin
the acetylation status of histones at the HOXA13 bound frag-
ments of the Enpp2 genetic locus even though it is also clear
that histones are acetylated at transcriptionally active genes.
Recruitment of HOXA13 to a target locus may not necessarily
inﬂuence the proportion of acetylated histones at a detectable
level using this method. This does not eliminate the possibility
that Enpp2 regulation in the HOXA13 expressing cells is
associated with other histone modiﬁcations. For example,
site-speciﬁc methylation of K9 and K4 in histone H3 has
been strongly implicated in roles in gene repression and
gene activation, respectively (62). The vast upregulation of
Enpp2 in the HOXA13 expressing cells implicates histone
modiﬁcation at this locus and the methylation state is a
compelling candidate to examine even though HOX
proteins have not been found to be associated with histone
methyltransferases.
Biological relevance
The direct regulation of Enpp2 expression by HOXA13 is
intriguing; however, the tissue-speciﬁc role this regulation
plays in vivo is unclear and needs further investigation.
Enpp2 was ﬁrst identiﬁed as ‘autocrine motility factor’ for
melanoma cells and later shown to be a member of the
ecto-nucleotide pyrophosphatase/phosphodiesterase family
of proteins (63). Recently, Enpp2 was found to be a regulator
of adhesive properties of the extra-cellular matrix (64) and to
catalyze the production of lysophosphatidic acid, a lipid medi-
atorwithpotentrolesindiversecelltypesforcellproliferation,
migration and survival (65,66). Many HOX downstream genes
that have been identiﬁed are known to be involved in these
processes (67,68). This suggests that induction of Enpp2
expression may allow HOXA13 to function in cell survival
or cell motility pathways.
HOXA13 speciﬁcally has been shown to be (i) expressed in
migrating premyoblasts (69), (ii) necessary for autopod out-
growth and development (53), (iii) involved in organization of
mesenchymalandendothelialcelllayersoftheumbilicalarter-
ies (70) and (iv) critical for apoptosis in the urethra without
which results in hypospadias (71). Thus, it is intriguing to
speculate a role for Enpp2 in these tissues.
Using Enpp2 as a direct target of HOXA13 will allow us to
thoroughly explore the domains of the HOXA13 protein that
are necessary for its transcriptional effects, determine whether
addition of known cofactors will augment the ability of
HOXA13 to report expression from the promoter, explore
the ability of other HOX family members to regulate expres-
sion from this promoter and explore the chromatin structure at
a known direct target containing multiple, necessary HOXA13
binding sites.
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